Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazem Atassi

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2016
Defining SOD1 ALS natural history to guide therapeutic clinical trial designTaha Bali, Wade Self, Jingxia Liu, et al.
Neurology|October 4, 2019
Prospective natural history study of <i>C9orf72</i> ALS clinical characteristics and biomarkersAlexander J Cammack, Nazem Atassi, Theodore Hyman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
JAMA Neurology|November 23, 2020
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialBrian J Wainger, Eric A Macklin, Steve Vucic, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2020
The NEALS primary lateral sclerosis registrySabrina Paganoni, Fabiola De Marchi, James Chan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 4, 2013
ALS Untangled No. 20: the Deanna protocol, Christina Fournier, Bedlack Bedlack, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2016
Defining SOD1 ALS natural history to guide therapeutic clinical trial designTaha Bali, Wade Self, Jingxia Liu, et al.
Neurology|October 4, 2019
Prospective natural history study of <i>C9orf72</i> ALS clinical characteristics and biomarkersAlexander J Cammack, Nazem Atassi, Theodore Hyman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
JAMA Neurology|November 23, 2020
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialBrian J Wainger, Eric A Macklin, Steve Vucic, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 11, 2020
The NEALS primary lateral sclerosis registrySabrina Paganoni, Fabiola De Marchi, James Chan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 4, 2013
ALS Untangled No. 20: the Deanna protocol, Christina Fournier, Bedlack Bedlack, et al.
Pageof 8